Sort   by:  
 Page size 
UnknownAdo-Trastuzumab Emtansine for Patients With HER2-Mutant Lung Cancers: Results From a Phase II Basket Trial.
Not available
S-EPMC6366814 | biostudies-literature
UnknownComparison of FDG-PET/CT and contrast-enhanced CT for monitoring therapy response in patients with metastatic breast cancer.
Not available
S-EPMC5526620 | biostudies-literature
UnknownImpact of FDG PET Imaging for Expanding Patient Eligibility and Measuring Treatment Response in a Genome-Driven Basket Trial of the Pan-HER Kinase Inhibitor, Neratinib.
Not available
S-EPMC7418635 | biostudies-literature
UnknownAMEERA-1 phase 1/2 study of amcenestrant, SAR439859, in postmenopausal women with ER-positive/HER2-negative advanced breast cancer.
Not available
S-EPMC9284491 | biostudies-literature
UnknownThe Contribution of MicroRNAs to the Inflammatory and Neoplastic Characteristics of Erdheim-Chester Disease.
Not available
S-EPMC7693724 | biostudies-literature
UnknownAccelerated single cell seeding in relapsed multiple myeloma.
Not available
S-EPMC7368016 | biostudies-literature
UnknownHER kinase inhibition in patients with HER2- and HER3-mutant cancers.
Not available
S-EPMC5808581 | biostudies-literature
UnknownEfficacy and Determinants of Response to HER Kinase Inhibition in HER2-Mutant Metastatic Breast Cancer.
Not available
S-EPMC7007377 | biostudies-literature
UnknownHER2-Mediated Internalization of Cytotoxic Agents in <i>ERBB2</i> Amplified or Mutant Lung Cancers.
Not available
S-EPMC7196485 | biostudies-literature
Sort   by:  
 Page size